| Tag | Content |
|---|
EnhancerAtlas ID | HS056-06529 |
Organism | Homo sapiens |
Tissue/cell | GC_B_cell |
Coordinate | chr17:45780110-45782480 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| E2F6 | MA0471.1 | chr17:45781798-45781809 | GGGCGGGAAGA | + | 6.14 | | EWSR1-FLI1 | MA0149.1 | chr17:45780790-45780808 | CCCTACTTCCTTTCTTTC | - | 6.09 | | RARA(var.2) | MA0730.1 | chr17:45780122-45780139 | GGGTCACGCAGAGGCCA | + | 6.48 | | ZNF263 | MA0528.1 | chr17:45780572-45780593 | CCCCCCACCCCTCTCTCCACC | - | 6.51 | | ZNF740 | MA0753.2 | chr17:45780567-45780580 | CCTCCCCCCCCAC | + | 6.87 |
|
| | Number of super-enhancer constituents: 4 | ID | Coordinate | Tissue/cell |
| SE_12381 | chr17:45780768-45784901 | CD3 | | SE_19405 | chr17:45779624-45785083 | CD4p_CD25-_Il17p_PMAstim_Th17 | | SE_20130 | chr17:45777573-45785406 | CD56 | | SE_22495 | chr17:45777469-45785540 | CD8_primiary |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH17I047700 | chr17 | 45777689 | 45787014 |
|
Enhancer Sequence | AAGAGCCACT GGGGGTCACG CAGAGGCCAA AGGCAGTGAT GAGGGAGGCG GTGGGAGCAG 60
AGCCCACCCT GCTCCTGAGG ATGCACAGGG AGGTAAAGAC CCTGACCCTT GGGGGGTTCC 120
CAGCCCAGGT GGAAGGCGCA GCACCCACAA CCCCCTTCTC TCTGGGCCCA GCTCCCCAGC 180
CTGGGGTTCC AGAGTGGGGC CTTTTGGAGG GTATGGCCGT GCTGAGGGGG AGGGGAAATG 240
CGGGGGGGGG AACTTCTTGA AGGGGATGAG GGCTCCGAAG GGACAGGGGG TCTGTGAGGG 300
GAATAAGGGC CCGGTAAGGG AGGGTGGGCT CATCTGTGCG GGGTCCATCT GGGAGAAGAT 360
GGGGACTCAG TATGGGCGAT GAGGAAAAAA CTATAGGCCT TTCTTTCTTC CCAACGTTGG 420
GGGCTCAGCG CTGCAGCCCG GGCCCTTTTC CGCACCACCT CCCCCCCCAC CCCTCTCTCC 480
ACCCACAAGC CTCTGCGTGG GCTGCGGTTA GTGGTGGGAA GAAGTGTGAA CTCGAGAGAG 540
AGGATGGAAA CTCTGCACGG AGGTCAAGGG CAGCGTGGGG TGGGTCAGGA CGGAAGTCGG 600
AGACCCCCGC ATACCCTGAG CGTAGCCTCA TGCCCCAGAA CCAGCAGGCC CAGGGCCTCC 660
CCCTTCACGC TTCTCACCCT CCCTACTTCC TTTCTTTCAA GTCTCCTTCG GCCAGGGCAC 720
CCGCGCTGCA CTCACAGGAG TTAACCCCTG AGCACTTGCA GCCTCGGGGG CTCCCAGAGG 780
CTAGGTGGGT CTGAGGGATG TGTGGGCTTT CAGCCCCAGT CCTTGGTGCT TTGCCTGCCA 840
GCAGGGTGGG GAGCAGCTCA TGCCAGCGCC CCCTCCCTCG ATGGGAAACG CCCATCTTCC 900
CTCCTTAAAC CGAAGCCACT AGGCTGCTGT CTCCAAAAAA AGGCTCAAAA CAAGTTTCCC 960
CCCTTCTCCA CCTATCTGCT AGGCACTCCC CTGAAATTTT TTTTTTTTTT TGTCCATGCC 1020
AGACACTATG CGAGGTGATT TACCTACAAA ATCTCATTTC ATTCTCACAA ACGTGATGTA 1080
GGTATTGTCC CCCTTTTACA GATGAGCAAA CTGAGGTGCA GGGAAGTGAA GTAATCTGAG 1140
AGTTCAGTAA GAAATTCAGT GCAGATGCCA AGTGGGTCCT GAGCAGATCG GGTGATGGCA 1200
CCTCTGCGGT GTGTTTCTGG TTCAGGTTCT TCTTCAGGTA GAAAGCCCTT ATATGAGGGG 1260
CAACCGTGTG ATTTGTTGAC CAGACTGGAT CACTTTTGAA AGTGAAAGGG GGCACTATTA 1320
ATAATTATGC TGGGGCAACT AGCGTGAACT GGGACAGTCC TAGGCAAACT GGGATCTCTG 1380
GGCACCCCAC CTATGTAGGA ACCCTGGTTT CCAGGCCTAC CCCTGAGCTG CTCCAATCAG 1440
CTGCATCTGG GAAGCTTTCT AGACCCGGGA TGTCAGCTCT GGTGGATTCG TGGCAGGGGC 1500
TGCCATGAAG AGCCAGGCTC TGGGGACCCC ACCAGTCATA GCTGGTCGAG GAGAGAGAAG 1560
GGGCTCAAGG CGCCCGAAAG GAAGTGGTGG AGCACTGGGT TGTTGCAAAG CAACTTCCTC 1620
CTCCCCGCCG GCCCGCAACC TCAAGTCCGT TCCACGGCCC GGTGCCTGTG GTCCCCTCCC 1680
CGAGGGTCGG GCGGGAAGAC TGATGCTGGG TGTGCCTGTG GGTGGTGGAA AGTTTGGTCC 1740
CTAAATTATC CCACAGGGGT GAGGTGGCTG GGGCAGCTGG GGGCAGCTTT GAGCAAGGAT 1800
GGAAGGGCCC TGGAAGGTTG GATTTCTGTT TTCCTCCCAA TTCTGAATCA GACGATGATT 1860
CTGACCACAT GGACAGCTCT AAACCTAACC CTAATCCTAA CCCTTTTACT GCTCCCGTCC 1920
CTGACTCTAA CCCTATCCCT GATCCTGACC TTCAGCTCTG TCCACAATCT TGGCCACGTG 1980
CTACATCAAC CCCACTCCTA GTCTGACCCT GGCTCCTTTA ATCCTGTCCT CAAGGCAGTC 2040
CCCAGCTTTA TCGTTTCCAG AAGTGTGTGA GATCTGTGAA TTATTCGTGG AAAGACTGAA 2100
TGAAAGGATG CGAAGCGTGG AATATTTGCA GCCCAGGGGG CCCTCCTTCC TGCCAGCTCT 2160
GCCATTTGCT CTCTGGCTCC TCCGAAGTTG CCAGCTTGGC AGGCTGAGGT GCCAAGAACC 2220
TGTGTTTGAA TCTGCTGTGT GCCACTGCCA CTCTGTGACC TTGAGCCAGC CTCTTAATCG 2280
CCCTGATTTT CTACTTCCAC ATGTGTCTAG CACCTTCCTA TCACCCCCAG GGAAGGGGTG 2340
GTGATTCTCA GGGCTTCCAG GCCACTGCCA 2370
|
